PD-1 Blockade in Anaplastic Thyroid Carcinoma

Capdevila, J; Wirth, LJ; Ernst, T; Aix, SP; Lin, CC; Ramlau, R; Butler, MO; Delord, JP; Gelderblom, H; Ascierto, PA; Fasolo, A; Fuhrer, D; Hutter-Kronke, ML; Forde, PM; Wrona, A; Santoro, A; Sadow, PM; Szpakowski, S; Wu, HQ; Bostel, G; Faris, J; Cameron, S; Varga, A; Taylor, M

Capdevila, J (corresponding author), Vall dHebron Univ Hosp, VHIO, Gastrointestinal & Endocrine Tumor Unit, Med Oncol Dept, Pg Vall dHebron 119-129, Barcelona 08035, Spain.

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (23): 2620

Abstract

PURPOSEAnaplastic thyroid carcinoma is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options for patient......

Full Text Link